Zobair M. Younossi

Biography

Zobair M Younossi, MD MPH FACG, FACP, AGAF, FAASLD Falls Church, USA Zobair M Younossi is the Professor and Chairman of the Department of Medicine at Inova Fairfax Medical Campus as well as the President of Inova Medicine, Inova Health System. Falls Church, Virginia, USA. Dr. Younossi earned his medical degree from the University of Rochester School of Medicine and Dentistry (Alpha Omega Alpha award 1989) in Rochester, NY, USA. He then completed his residency in internal medicine with a fellowship in gastroenterology and hepatology at Scripps Clinic and Research Foundation in La Jolla, California, USA, while earning his master of public health degree with multiple honours from San Diego State University School of Public Health, San Diego, California, USA. He served as Staff Hepatologist and Senior Researcher at the Cleveland Clinic Foundation, Cleveland, Ohio, USA, before establishing the Canter for Liver Diseases at Inova Fairfax Hospital, which is now renowned for outcomes research in liver disease as well as pioneering research in non-alcoholic fatty liver disease (NAFLD). He served as Vice President and Chairman of Research for Inova Health System (2010-2022) and is the current President and Chairman of the Board of Trustees of the Chronic Liver Disease Foundation (2018-Present) and the Board of Inova Health System Foundation (2011-Present). He is also the Chairman of the Global NASH Council and the associated Global Liver and Global NASH Registries. Dr.Younossi specializes in hepatology has authored 733 articles, 3 books, 7 journal supplements, 26 book chapters and 1059 abstracts presented at the international scientific meetings and has an H-index of 108. He is highly sought-after speaker and has provided over 500 faculty lectures in national and international meetings. Dr.Younossi has also served as the co-editor of Liver International, Associate Editor of J of Hepatology and on the editorial board of a number of important medical journals. He has represented the American Association of Liver Disease and American Gastroenterological Association at different congressional meetings.